Fecal immunohistochemical test (FIT) as screening tool for colorectal cancer (CRC) among asymptomatic healthy adults, aged 45 years old and above

HTA Council Recommendation (as of 26 February 2025) The HTA Council recommends qualitative Fecal immunohistochemical test (FIT) as an annual screening test for colorectal cancer (CRC) for apparently healthy adults aged 50 years and above for financing of DOH and/or PhilHealth (See below for more details). Relevant Information Evidence and Relevant Documents Assessment History Back continue reading : Fecal immunohistochemical test (FIT) as screening tool for colorectal cancer (CRC) among asymptomatic healthy adults, aged 45 years old and above

Visualization in acetic acid (VIA) for screening of cervical cancer

HTA Council Recommendation (as of 13 March 2025) The HTA Council positively recommends Visual Acetic Acid (VIA) for financing of the Department of Health (DOH) and/or PhilHealth. VIA is recommended for cervical cancer screening in women ages 30-65 years every 3 years, in settings wherein HPV DNA testing is still not operational (See below for continue reading : Visualization in acetic acid (VIA) for screening of cervical cancer

Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)

I. Assessment A. Policy and Research Question Policy Question: Should ECMO for COVID-19 patients with acute respiratory distress syndrome (ARDS) be recommended for use and covered by PhilHealth?            Research Questions: Treatment guidelines and evidence synthesis on the use of ECMO Clinical efficacy / effectiveness and safety Among critically ill COVID-19 patients continue reading : Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)